Nassif Anriada, Ostermayer Daniel G, Hoang Kim B, Claiborne Mary K, Camp Elizabeth A, Shah Manish I
Prehosp Emerg Care. 2018 Jul-Aug;22(4):457-465. doi: 10.1080/10903127.2017.1408727. Epub 2018 Jan 19.
Respiratory distress due to asthma is a common reason for pediatric emergency medical services (EMS) transports. Timely initiation of asthma treatment, including glucocorticoids, improves hospital outcomes. The impact of EMS-administered glucocorticoids on hospital-based outcomes for pediatric asthma patients is unknown.
The objective of this study was to evaluate the effect of an evidence-based pediatric EMS asthma protocol update, inclusive of oral glucocorticoid administration, on time to hospital discharge.
This was a retrospective cohort study of children (2-18 years) with an acute asthma exacerbation transported by an urban EMS system to 10 emergency departments over 2 years. The investigators implemented an EMS protocol update one year into the study period requiring glucocorticoid administration for all patients, with the major change being inclusion of oral dexamethasone (0.6 mg/kg, max. dose = 10 mg). Protocol implementation included mandatory paramedic training. Data was abstracted from linked prehospital and hospital records. Continuous data were compared before and after the protocol change with the Mann-Whitney test, and categorical data were compared with the Pearson χ test.
During the study period, 482 asthmatic children met inclusion criteria. After the protocol change, patients were more likely to receive a prehospital glucocorticoid (11% vs. 18%, p = 0.02). Median total hospital time after the protocol change decreased from 6.1 hours (95% CI: 5.4-6.8) to 4.5 hours (95% CI: 4.2-4.8), p < 0.001. Total care time, defined as time from ambulance arrival to hospital discharge, also decreased [6.6 hours (95% CI: 5.8-7.3) vs. 5.2 hours (95% CI: 4.8-5.6), p = 0.01]. Overall, patients were less likely to be admitted to the hospital (30% vs. 21%, p = 0.02) after the change. Those with more severe exacerbations were less likely to be admitted to a critical care unit (82% vs. 44%, p = 0.02) after the change, rather than an acute care floor.
Prehospital protocol change for asthmatic children is associated with shorter total hospital and total care times. This protocol change was also associated with decreased hospitalization rates and less need for critical care in those hospitalized. Further study is necessary to determine if other factors also contributed.
哮喘引起的呼吸窘迫是儿科紧急医疗服务(EMS)转运的常见原因。及时启动哮喘治疗,包括使用糖皮质激素,可改善医院治疗效果。EMS给予糖皮质激素对儿科哮喘患者基于医院的治疗效果的影响尚不清楚。
本研究的目的是评估基于证据的儿科EMS哮喘方案更新(包括口服糖皮质激素给药)对出院时间的影响。
这是一项回顾性队列研究,研究对象为2至18岁因急性哮喘加重由城市EMS系统转运至10个急诊科的儿童,为期2年。研究人员在研究期间的第1年实施了一项EMS方案更新,要求对所有患者给予糖皮质激素,主要变化是加入口服地塞米松(0.6mg/kg,最大剂量=10mg)。方案实施包括对护理人员的强制性培训。数据从相关的院前和医院记录中提取。连续数据在方案改变前后用Mann-Whitney检验进行比较,分类数据用Pearson χ检验进行比较。
在研究期间,482名哮喘儿童符合纳入标准。方案改变后,患者更有可能接受院前糖皮质激素治疗(11%对18%,p = 0.02)。方案改变后,总住院时间中位数从6.1小时(95%CI:5.4 - 6.8)降至4.5小时(95%CI:4.2 - 4.8),p < 0.001。总护理时间(定义为从救护车到达至出院的时间)也有所减少[6.6小时(95%CI:5.8 - 7.3)对5.2小时(95%CI:4.8 - 5.6),p = 0.01]。总体而言,方案改变后患者住院的可能性较小(30%对21%,p = 0.02)。病情加重较严重的患者在方案改变后入住重症监护病房的可能性较小(82%对44%,p = 0.02),而不是入住急性护理病房。
哮喘儿童的院前方案改变与缩短总住院时间和总护理时间相关。这一方案改变还与住院率降低以及住院患者对重症监护的需求减少相关。有必要进一步研究以确定是否还有其他因素也起了作用。